diclofenac has been researched along with tulathromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durgut, R; Guzel, M; Karakurum, MC; Mamak, N | 1 |
| Abdel-Daim, MM; Eltaysh, R; Hassan, A; Mousa, SA | 1 |
1 trial(s) available for diclofenac and tulathromycin
| Article | Year |
|---|---|
Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Cattle; Cattle Diseases; Clonixin; Diclofenac; Disaccharides; Double-Blind Method; Drug Therapy, Combination; Heterocyclic Compounds; Respiratory Rate; Respiratory Tract Diseases | 2010 |
1 other study(ies) available for diclofenac and tulathromycin
| Article | Year |
|---|---|
Lycopene Attenuates Tulathromycin and Diclofenac Sodium-Induced Cardiotoxicity in Mice.
Topics: Animals; Biomarkers; Cardiotoxicity; Carotenoids; Creatine Kinase, MB Form; Diclofenac; Disaccharides; Heart; Heterocyclic Compounds; Immunohistochemistry; L-Lactate Dehydrogenase; Lipid Peroxidation; Lycopene; Male; Mice; Myocardium; Protective Agents | 2018 |